{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:45:15Z","timestamp":1792154715893,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vhri.2026.102143","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:49:31Z","timestamp":1792151371000},"page":"102143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Analysis of Medical Device Regulatory Frameworks Across Countries"],"prefix":"10.1016","author":[{"given":"Bunchai","family":"Chongmelaxme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nargis","family":"Saharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok Pim","family":"Kua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vhri.2026.102143_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/ehjqcco\/qcab059","article-title":"Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)","volume":"8","author":"Fraser","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"10.1016\/j.vhri.2026.102143_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41746-024-01021-y","article-title":"Beyond the 510(k): the regulation of novel moderate-risk medical devices, intellectual property considerations, and innovation incentives in the FDA\u2019s de novo pathway","volume":"7","author":"Aboy","year":"2024","journal-title":"npj Digit Med"},{"issue":"7","key":"10.1016\/j.vhri.2026.102143_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMp0905338","article-title":"The new Sentinel Network\u2014improving the evidence of medical-product safety","volume":"361","author":"Platt","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vhri.2026.102143_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.vhri.2026.102143_bib6","series-title":"Principles of medical devices classification. GHTF\/SG1\/N15:2006. Study Group 1 final document","year":"2006"},{"key":"10.1016\/j.vhri.2026.102143_bib7","series-title":"Medical devices: conformity assessment and the UKCA mark","year":"2020"},{"issue":"4","key":"10.1016\/j.vhri.2026.102143_bib8","first-page":"85","article-title":"Medical device classification systems across major regulators","volume":"17","author":"Anjali","year":"2025","journal-title":"J Pharm Sci Res"},{"key":"10.1016\/j.vhri.2026.102143_bib10","author":"Noonan"},{"issue":"6","key":"10.1016\/j.vhri.2026.102143_bib11","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3233\/THC-220284","article-title":"Post-market surveillance of medical devices: a review","volume":"30","author":"Badnjevi\u0107","year":"2022","journal-title":"Technol Health Care"},{"issue":"3","key":"10.1016\/j.vhri.2026.102143_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/14737167.2024.2431234","article-title":"Regulatory perspectives on post-market evidence generation schemes for high-risk medical devices: a systematic review","volume":"25","author":"Aranda","year":"2024","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"4","key":"10.1016\/j.vhri.2026.102143_bib13","first-page":"269","article-title":"Clinical evaluation requirements under the new European Union medical device regulation","volume":"6","author":"Hern\u00e1ndez Hern\u00e1ndez","year":"2024","journal-title":"REC Interv Cardiol"},{"issue":"1","key":"10.1016\/j.vhri.2026.102143_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jse.2024.08.011","article-title":"European medical devices regulation: a plea for ensuring safety without slowing access to innovation","volume":"34","author":"Pe\u00f1arrubia-Ortiz","year":"2025","journal-title":"J Shoulder Elbow Surg"},{"issue":"10","key":"10.1016\/j.vhri.2026.102143_bib15","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1016\/j.xphs.2022.07.011","article-title":"Analysis of the renewed European Medical Device Regulations in the frame of the non\u2014EU regulatory landscape during the COVID facilitated change","volume":"111","author":"Kanti","year":"2022","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.vhri.2026.102143_bib16","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/ph18060876","article-title":"Advancing regulatory oversight of medical device trials to align with clinical drug standards in the European Union","volume":"18","author":"Pannonhalmi","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.vhri.2026.102143_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5530\/jyp.2016.1.3","article-title":"Medical device regulations: a current perspective","volume":"8","author":"Gupta","year":"2015","journal-title":"J Young Pharm"},{"issue":"7","key":"10.1016\/j.vhri.2026.102143_bib18","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1007\/s00210-025-03843-3","article-title":"Evidence-based recommendations for comprehensive regulatory guidelines in medical devices: the imperative for global harmonization","volume":"398","author":"Rimpi","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"10.1016\/j.vhri.2026.102143_bib19","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/s43441-024-00696-5","article-title":"Current application of the Medical Device Single Audit Program (MDSAP) as a global regulatory reliance framework for the inspection of medical devices","volume":"58","author":"Ishibashi","year":"2024","journal-title":"Ther Innov Regul Sci"},{"issue":"5","key":"10.1016\/j.vhri.2026.102143_bib20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jvir.2017.12.022","article-title":"New regulatory framework for medical devices in Japan: current regulatory considerations regarding clinical studies","volume":"29","author":"Konishi","year":"2018","journal-title":"J Vasc Interv Radiol"},{"issue":"0","key":"10.1016\/j.vhri.2026.102143_bib21","article-title":"The medical device regulation of the European Union intensifies focus on clinical benefits of devices","volume":"0","author":"Wilkinson","year":"2019","journal-title":"Ther Innov Regul Sci"},{"issue":"6","key":"10.1016\/j.vhri.2026.102143_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/ACO.0000000000000391","article-title":"Understanding medical device regulation","volume":"29","author":"Galgon","year":"2016","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.vhri.2026.102143_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2025.1586070","article-title":"Regulatory landscape of accelerated approval pathways for medical devices in the United States and the European Union","volume":"7","author":"Gupte","year":"2025","journal-title":"Front Med Technol"},{"issue":"4","key":"10.1016\/j.vhri.2026.102143_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/17434440.2017.1299572","article-title":"The current situation and development of medical device testing institutes in China","volume":"14","author":"Yang","year":"2017","journal-title":"Expert Rev Med Devices"},{"issue":"4","key":"10.1016\/j.vhri.2026.102143_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.36290\/csf.2015.029","article-title":"Legislative aspects of the development of medical devices","volume":"64","author":"Mare\u0161ov\u00e1","year":"2015","journal-title":"Ceska Slov Farm"},{"issue":"5","key":"10.1016\/j.vhri.2026.102143_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0325250","article-title":"Scoping review on regulation, implementation and postmarket surveillance of medical devices","volume":"20","author":"Damkj\u00e6r","year":"2025","journal-title":"PLOS One"},{"issue":"suppl 2","key":"10.1016\/j.vhri.2026.102143_bib27","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.injury.2019.10.071","article-title":"Regulatory clearance: how are outcome measurements critical?","volume":"51","author":"Fink","year":"2020","journal-title":"Injury"},{"issue":"9","key":"10.1016\/j.vhri.2026.102143_bib28","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pds.4859","article-title":"EU postmarket surveillance plans for medical devices","volume":"28","author":"Pane","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.vhri.2026.102143_bib29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.7326\/M23-0454","article-title":"The new European medical device regulation: balancing innovation and patient safety","volume":"176","author":"Bretthauer","year":"2023","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.vhri.2026.102143_bib30","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1109\/JBHI.2019.2952906","article-title":"Integrated security, safety, and privacy risk assessment framework for medical devices","volume":"24","author":"Yaqoob","year":"2019","journal-title":"IEEE J Biomed Health Inform"},{"issue":"20","key":"10.1016\/j.vhri.2026.102143_bib31","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.3390\/app14209304","article-title":"Global regulatory challenges for medical devices: impact on innovation and market access","volume":"14","author":"Amaral","year":"2024","journal-title":"Appl Sci"},{"issue":"1","key":"10.1016\/j.vhri.2026.102143_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/2168479017716712","article-title":"A comparative study of medical device regulations:: US, Europe, Canada, and Taiwan","volume":"52","author":"Chen","year":"2018","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.vhri.2026.102143_bib38","series-title":"Medical devices regulation","year":"2024"},{"key":"10.1016\/j.vhri.2026.102143_bib47","series-title":"WHO global model regulatory framework for medical devices including in vitro diagnostic medical devices","year":"2017"},{"issue":"3","key":"10.1016\/j.vhri.2026.102143_bib48","first-page":"40","article-title":"The Medical Devices Special Access Program in Canada: a scoping study","volume":"13","author":"Maier","year":"2018","journal-title":"Healthc Policy"},{"issue":"1","key":"10.1016\/j.vhri.2026.102143_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/1468-0009.12043","article-title":"Improving medical device regulation: the United States and Europe in perspective","volume":"92","author":"Sorenson","year":"2014","journal-title":"Milbank Q"},{"issue":"9","key":"10.1016\/j.vhri.2026.102143_bib50","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMhle1113918","article-title":"Regulation of medical devices in the United States and European Union","volume":"366","author":"Kramer","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vhri.2026.102143_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001519","article-title":"Postmarket surveillance of medical devices: a comparison of strategies in the US, EU, Japan, and China","volume":"10","author":"Kramer","year":"2013","journal-title":"PLOS Med"},{"key":"10.1016\/j.vhri.2026.102143_bib52","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2261-14-154","article-title":"Contrasting clinical evidence for market authorisation of cardio-vascular devices in Europe and the USA: a systematic analysis of 10 devices based on Austrian pre-reimbursement assessments","volume":"14","author":"Wild","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"10.1016\/j.vhri.2026.102143_bib53","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/jce.70248","article-title":"Approval lag for ablation catheters: a comparative analysis of regulatory timelines in the European Union, United States, and Japan","volume":"37","author":"Oguri","year":"2026","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.vhri.2026.102143_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1415319","article-title":"More than red tape: exploring complexity in medical device regulatory affairs","volume":"11","author":"Han","year":"2024","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.vhri.2026.102143_bib55","doi-asserted-by":"crossref","DOI":"10.1080\/23311916.2023.2261236","article-title":"Challenges faced by manufacturers with clinical evaluation under the new European Medical Device Regulations","volume":"10","author":"Kearney","year":"2023","journal-title":"Cogent Eng"},{"key":"10.1016\/j.vhri.2026.102143_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/RMHP.S346928","article-title":"Critical factors and economic methods for regulatory impact assessment in the medical device industry","volume":"15","author":"Maci","year":"2022","journal-title":"Risk Manag Healthc Policy"},{"issue":"8","key":"10.1016\/j.vhri.2026.102143_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-009798","article-title":"Regulatory reliance for convergence and harmonisation in the medical device space in Asia-Pacific","volume":"7","author":"Xu","year":"2022","journal-title":"BMJ Glob Health"},{"issue":"6","key":"10.1016\/j.vhri.2026.102143_bib58","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/ph18060876","article-title":"Advancing regulatory oversight of medical device trials to align with clinical drug standards in the European Union","volume":"18","author":"Pannonhalmi","year":"2025","journal-title":"Pharmaceuticals"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926005583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926005583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:49:36Z","timestamp":1792151376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926005583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S2212109926005583"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.102143","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Analysis of Medical Device Regulatory Frameworks Across Countries","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.102143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"102143"}}